Florestan Koll
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 22
- Bladder and Urothelial Cancer Treatments 21
- Urinary and Genital Oncology Studies 15
-
- Prostate Cancer Treatment and Research 14
- Prostate Cancer Diagnosis and Treatment 9
- Co-authors
- Felix K.‐H. Chun (21 shared papers)Séverine Banek (14 shared papers)Jürgen E. Gschwend (8 shared papers)Jens Köllermann (9 shared papers)Mike Wenzel (17 shared papers)Henning Reis (9 shared papers)Benedikt Hoeh (17 shared papers)Peter J. Wild (9 shared papers)
In The Last Decade
Florestan Koll
34 papers receiving 214 citations
Peers
Comparison fields: 5 of 32
- Oncology 80
- Urology 18
- Pulmonary and Respiratory Medicine 87
- Surgery 97
- Cancer Research 31
Countries citing papers authored by Florestan Koll
This map shows the geographic impact of Florestan Koll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florestan Koll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florestan Koll more than expected).
Fields of papers citing papers by Florestan Koll
This network shows the impact of papers produced by Florestan Koll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florestan Koll. The network helps show where Florestan Koll may publish in the future.
Co-authors
The 25 scholars most cited alongside Florestan Koll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 25 | |
| 2 | 2020 | 19 | |
| 3 | 2018 | 18 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 15 | |
| 6 | 2024 | 11 | |
| 7 | 2023 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2020 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2024 | 3 |
About Florestan Koll
Florestan Koll is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 38 papers that have together received 214 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (15 papers), Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Lipids, and Metabolism (4 papers) and Urological Disorders and Treatments (3 papers). The work is most often cited by research in Oncology (80 citations), Urology (18 citations), Pulmonary and Respiratory Medicine (87 citations), Surgery (97 citations) and Cancer Research (31 citations). Florestan Koll has collaborated with scholars based in Germany, Türkiye and Canada. Frequent co-authors include Felix K.‐H. Chun, Séverine Banek, Jürgen E. Gschwend, Jens Köllermann, Mike Wenzel, Henning Reis, Benedikt Hoeh, Peter J. Wild, Sebastian C. Schmid and Philipp Mandel. Their work appears in journals such as The Prostate, Annals of Oncology, Urologic Oncology Seminars and Original Investigations, BMC Cancer and World Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.